Abstract
The common polymorphic variant in the 5′ untranslated region of the excision repair cross-complementation group 5 (ERCC5) gene was described to generate an upstream open reading frame that regulates both the basal ERCC5 expression and its ability to be synthesized following DNA damage. This variant was reported to affect response to platinum therapy in a cohort of patients with pediatric ependymoma. The role of this variant was investigated in two cohorts of cancer patients, specifically in non-small-cell lung cancer (NSCLC) patients (N = 137) and in epithelial ovarian carcinoma (EOC) patients (N = 240), treated in first-line with platinum-based compounds. Differently from what reported for pediatric ependymoma, the analysis of the polymorphism in NSCLC patients cohort was not able to detect any difference among patients harboring different genotypes both in progression free survival (HR = 0.93; 95%CI 0.64–1.33; p-value = 0.678) and overall survival (HR = 0.90; 95%CI 0.62–1.33; p-value = 0.625). These data were corroborated in a EOC patients cohort, where similar progression free survival (HR = 0.91; 95% CI 0.67–1.24; p-value = 0.561) and overall survival (HR = 0.98; 95% CI 0.71–1.35; p-value = 0.912) were found for the different genotypes. These data, obtained in appropriately sized populations, indicate that the effect of this ERCC5 polymorphism is likely to be relevant only in specific tumors.
Highlights
The common polymorphic variant in the 5′ untranslated region of the excision repair crosscomplementation group 5 (ERCC5) gene was described to generate an upstream open reading frame that regulates both the basal Excision repair cross-complementation group 5 (ERCC5) expression and its ability to be synthesized following DNA damage
Excision repair cross-complementation group 5 (ERCC5), known as Xeroderma pigmentosum group G (XPG), is a gene belonging to nucleotide excision repair (NER) that encodes a single-strand specific endonuclease that makes the 3′incision in the DNA repair process following damage
It is well known that some somatic mutations or rearrangements such as gene duplication or deletion in the tumor define subgroup of patients more responsive to chemotherapy[11,12]
Summary
The common polymorphic variant in the 5′ untranslated region of the excision repair crosscomplementation group 5 (ERCC5) gene was described to generate an upstream open reading frame that regulates both the basal ERCC5 expression and its ability to be synthesized following DNA damage This variant was reported to affect response to platinum therapy in a cohort of patients with pediatric ependymoma. The common polymorphic variant in the ERCC5 5′untranslated region (rs751402) was described to generate an upstream Open Reading Frame (uORF) that affects both the basal ERCC5 expression and its ability to be synthesized following DNA damage This variant was reported to affect the response to platinum therapy in a cohort www.nature.com/scientificreports/
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
